Significant advances in identification of etiologies of inherited thro
mbosis have been recently reported. A point mutation in coagulation fa
ctor V (factor V Leiden) results in resistance to activated protein C
and probably repesents the most common genetic risk factor for venous
thrombosis. A metabolic disorder, homocysteinemia, is now known to be
an important risk factor for both arterial and venous thrombosis. Many
patients with recurrent thrombosis will have more than one genetic ri
sk factor identified. Recognition of these new disorders should permit
a diagnosis to be achieved in at least half of patients evaluated for
inherited thrombosis. (C) 1997 Wiley-Liss, Inc.